Galectin Therapeutics shares owned by Summit Trail Advisors
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Summit Trail Advisors
from 13F filings
Historical chart of Summit Trail Advisors investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Summit Trail Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Summit Trail Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $85k | 20k | 4.24 |
| 2025-06-30 | $42k | 20k | 2.11 |
| 2024-09-30 | $55k | 20k | 2.75 |
| 2024-06-30 | $45k | 20k | 2.26 |
| 2024-03-31 | $48k | 20k | 2.39 |
| 2023-12-31 | $33k | 20k | 1.66 |
| 2023-09-30 | $38k | 20k | 1.92 |
| 2023-06-30 | $29k | 20k | 1.44 |
| 2022-09-30 | $39k | 24k | 1.63 |
| 2022-06-30 | $31k | 24k | 1.30 |
| 2022-03-31 | $38k | 24k | 1.59 |